Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

NARecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

proton plus carbon ion radiation

All patients received whole pelvis and prostate region proton irradiation of 46 GyE in 23 fractionsfollowed by localized carbon ion irradiation of 32GyE in 8 fractions to the prostate region. The dose to metastatic LN was escalated using simultaneous integrated boost (SIB) technique. The dose was 60-62.1GyE in 23 fractions as much as dose constraints. All patients will be recommened receive 2-3 years endocrine therapy.

Trial Locations (1)

Unknown

RECRUITING

Shanghai Proton and Heavy Ion Center, Shanghai

All Listed Sponsors
lead

Shanghai Proton and Heavy Ion Center

OTHER